{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:08:22Z","timestamp":1790525302464,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1053\/j.ajkd.2005.08.018","type":"journal-article","created":{"date-parts":[[2005,12,8]],"date-time":"2005-12-08T11:38:01Z","timestamp":1134041881000},"page":"1080-1087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Underuse of ACE Inhibitors and Angiotensin II Receptor Blockers in Elderly Patients With Diabetes"],"prefix":"10.1053","volume":"46","author":[{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisa","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Avorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2005.08.018_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/diacare.21.4.518","article-title":"Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults","volume":"21","author":"Harris","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1053\/j.ajkd.2005.08.018_bib2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2337\/diacare.23.9.1278","article-title":"Diabetes trends in the US, 1990-1998","volume":"23","author":"Mokdad","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1053\/j.ajkd.2005.08.018_bib3","unstructured":"US Renal Data System: USRDS 2003 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2003"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2005.08.018_bib4","first-page":"S79","article-title":"Nephropathy in diabetes","volume":"27","author":"Molitch","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1053\/j.ajkd.2005.08.018_bib5","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1681\/ASN.V1482084","article-title":"Cholesterol and the risk of renal dysfunction in apparently healthy men","volume":"14","author":"Schaeffner","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2005.08.018_bib6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of new-onset kidney disease in a community-based population","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2005.08.018_bib7","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archinte.164.14.1519","article-title":"Lifetime nonnarcotic analgesic use and decline in renal function in women","volume":"164","author":"Curhan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib8","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.1996.00440030080010","article-title":"Long-term renoprotective effect of angiotensin-converting-enzyme inhibition in non-insulin-dependent diabetes mellitus","volume":"156","author":"Ravid","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with neuropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0272-6386(95)90636-3","article-title":"Screening and management of microalbuminuria in patients with diabetes mellitus","volume":"25","author":"Bennett","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2005.08.018_bib14","first-page":"S5","article-title":"Standards of medical care for patients with diabetes mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2005.08.018_bib15","first-page":"S1","article-title":"Clinical practice recommendations 2004","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1053\/j.ajkd.2005.08.018_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O","article-title":"A comparison of goodness-of-fit tests for the logistic regression model","volume":"16","author":"Hosmer","year":"1997","journal-title":"Stat Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1525-1497.2004.30264.x","article-title":"Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes","volume":"19","author":"Rosen","year":"2004","journal-title":"J Gen Intern Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib18","first-page":"588","article-title":"A word from WIPRO","volume":"95","author":"Gold","year":"1996","journal-title":"Wis Med J"},{"key":"10.1053\/j.ajkd.2005.08.018_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/qjmed\/92.8.443","article-title":"The care of patients with diabetic nephropathy","volume":"92","author":"Dunn","year":"1999","journal-title":"Q J Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib20","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1345\/aph.19346","article-title":"The use of ACE inhibitors as renoprotective agents in Medicaid patients with diabetes","volume":"34","author":"Scarsi","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.ajkd.2005.08.018_bib21","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1056\/NEJMsa022615","article-title":"The quality of care delivered to adults in the United States","volume":"348","author":"McGlynn","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7326\/0003-4819-141-4-200408170-00007","article-title":"Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care","volume":"141","author":"Kerr","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000188358","article-title":"Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal disease","volume":"69","author":"Liou","year":"1995","journal-title":"Nephron"},{"issue":"suppl 5","key":"10.1053\/j.ajkd.2005.08.018_bib24","first-page":"S265","article-title":"Guidelines for improving the care of the older person with diabetes mellitus","volume":"51","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1053\/j.ajkd.2005.08.018_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"The effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2005.08.018_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin dependent diabetes and hypertension","volume":"338","author":"Estacio","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib27","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1097\/00004872-200018110-00020","article-title":"Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients","volume":"18","author":"Lindholm","year":"2000","journal-title":"J Hypertens"},{"key":"10.1053\/j.ajkd.2005.08.018_bib28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/diacare.21.4.597","article-title":"Outcome results of the Fosinopril versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM","volume":"21","author":"Tatti","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1053\/j.ajkd.2005.08.018_bib29","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE)","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2005.08.018_bib30","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.1996.03540180029029","article-title":"Persons with chronic conditions","volume":"276","author":"Hoffman","year":"1995","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2005.08.018_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11606-006-0001-7","article-title":"The effect of comorbidity on use of thrombolysis or aspirin in patients with acute myocardial infarction eligible for treatment","volume":"12","author":"McLaughlin","year":"1997","journal-title":"J Gen Intern Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib32","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.162.20.2269","article-title":"Prevalence, expenditures, and complications of multiple chronic conditions in the elderly","volume":"162","author":"Wolff","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/01.ASN.0000046047.66958.C3","article-title":"A propensity analysis of late vs. early nephrologist referral and mortality on dialysis","volume":"14","author":"Winkelmayer","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2005.08.018_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.ajkd.2005.04.029","article-title":"Identification of individuals with chronic kidney disease from Medicare claims data\u2014A validation study","volume":"46","author":"Winkelmayer","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2005.08.018_bib35","first-page":"1358","article-title":"ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy","volume":"15","author":"Lewis","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2005.08.018_bib36","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1056\/NEJMsb042458","article-title":"Potential pitfalls of disease-specific guidelines for patients with multiple conditions","volume":"351","author":"Tinetti","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2005.08.018_bib37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638605012114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638605012114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:31:22Z","timestamp":1759455082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638605012114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0272638605012114"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2005.08.018","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Underuse of ACE Inhibitors and Angiotensin II Receptor Blockers in Elderly Patients With Diabetes","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2005.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}